Efficacy of pulsed radiofrequency combined with Bupivacaine liposomes in patients of Zoster-associated pain

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400093669

Enrollment

Unknown

Registered

2024-12-10

Start date

2024-05-14

Completion date

Unknown

Last updated

2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster neuralgia

Interventions

Bupivacaine liposomes:pulsed radiofrequency combined with Bupivacaine liposomes

Bupivacaine:pulsed radiofrequency combined with Bupivacaine

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.ZAP was diagnosed according to the Consensus of Chinese Experts on herpes zoster Diagnosis and Treatment, and the medical records were complete; 2.VAS score > 3; 3.Patients with shingles on the neck, chest, and lumbar;

Exclusion criteria

Exclusion criteria: Long term use of hormones; Injection site infection; Abnormal coagulation function; Liver and kidney dysfunction; Pain area accompanied by Along with spinal tumors, fractures, and disc herniation

Design outcomes

Primary

Measure	Time frame
NRS;	—

Secondary

Measure	Time frame
Daily living ability rating scale;Use of postoperative analgesics tramadol, gabapentin, or pregabalin;Adverse event rate;incidence of PHN;Plasma inflammatory factor;	—

Countries

China

Contacts

Public Contactyingying lou

Ningbo Medical Centre Lihuili Hospital

605570569@qq.com+86 17857436857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026